- Home
- CRK vs ARWR Comparison
CRK vs ARWR Comparison
Compare CRK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRK | ARWR |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 8.0B |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CRK | ARWR |
|---|---|---|
| Price | $21.03 | $62.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $22.30 | ★ $81.50 |
| AVG Volume (30 Days) | 2.0M | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 288.16 | 99.80 |
| EPS | ★ 1.43 | 0.22 |
| Revenue | ★ $555,231,000.00 | $16,142,321.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.48 | N/A |
| P/E Ratio | ★ $15.32 | $262.37 |
| Revenue Growth | ★ 32.11 | N/A |
| 52 Week Low | $14.65 | $10.66 |
| 52 Week High | $31.17 | $76.76 |
Technical Indicators
Market Signals| Indicator | CRK | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 56.75 |
| Support Level | $20.35 | $60.60 |
| Resistance Level | $22.07 | $66.37 |
| Average True Range (ATR) | 1.25 | 3.10 |
| MACD | 0.13 | 0.62 |
| Stochastic Oscillator | 38.26 | 94.65 |
Price Performance
Historical ComparisonAbout CRK Comstock Resources Inc.
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. The company's oil and gas operations are concentrated in Louisiana and Texas.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.